For the Alzheimer's trial you mentioned that "cond
Post# of 148096
Quote:
For the Alzheimer's trial you mentioned that "conditional approval is possible on a phase 2 for that disease so a phase 3 would be unnecessary."
My question is this: Is that also true for the mssCRC trial? Is it possible that conditional approval on a phase 2 for that disease would make a phase 3 unnecessary?
Quote:
If I remember right, others also mentioned great ORR results can basis Cytodyn filing for early, Conditional Approval.
Quote:
In mssCRC with that size of patient population it's highly unlikely.
https://investorshangout.com/post/view?id=6727402
Besides the patient population size the difference between mssCRC and Alzheimer's is that there is no really viable approved drug for Alzheimer's.